BIOA BioAge Labs, Inc.: institutional ownership and insider trading
154 funds reported holding $1.01B of BioAge Labs, Inc. in their latest 13F filings; in Q2 2026 funds net bought $105M, with 25 new positions and 19 funds selling out; over the last 12 months insiders bought $0 and sold $7.79M on the open market.
Famous investors holding BIOA
- D. E. Shaw (D. E. Shaw & Co.): $18.2M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $4.06M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.07M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.40M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.50M, 0.0% of the portfolio
Largest institutional holders of BIOA
- a16z Capital Management, L.L.C. — $79.2M
- BlackRock, Inc. (BLK) — $69.8M
- Cormorant Asset Management, LP — $58.6M
- Sofinnova Investments, Inc. — $56.2M
- Jupiter Topco LLC — $52.6M
- Octagon Capital Advisors LP — $42.8M
- RA CAPITAL MANAGEMENT, L.P. — $41.0M
- MPM BioImpact LLC — $40.9M
- VANGUARD CAPITAL MANAGEMENT LLC — $37.8M
- JANUS HENDERSON GROUP PLC (JHG) — $36.6M
Recent BIOA insider trades
- Jun 30, 2026: Barton Shane sold 62,566 shares ($1.58M)
- Apr 1, 2026: Rubin Paul D sold 8,820 shares ($157K)
- Mar 2, 2026: Rubin Paul D sold 7,433 shares ($151K)
- Feb 2, 2026: Rubin Paul D sold 7,433 shares ($139K)
5%+ owners
- Cormorant Asset Management, LP: 5.4% (Schedule 13G/A, filed Aug 14, 2026)
- BlackRock, Inc.: 5.0% (Schedule 13G, filed Apr 27, 2026)